Multiplexed high-content assay for toxicity profiling using live ipsc-derived cardiomyocyte lines with lineage-specific barcoding
Ended Project Grant Awarded Last action
- Award ID
- R44TR002572
- Recipient
-
Cairn Biosciences Inc. UEI LWZWY2J1M2J4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,936
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Originally
- Funding
-
- $1,999,938.88 Federal
- -$3.06 Non-federal
- Place of performance
- San Francisco, CA 94158, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$3 | $0 | |
| Amendment | -$3 | -$3 | |
| Amendment | $821,559 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $1,178,386 | $0 |
Quick answers
Who received award R44TR002572?
R44TR002572 was awarded to Cairn Biosciences Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on August 15, 2018.
How much is award R44TR002572 worth?
$1,999,936 has been obligated on R44TR002572: $1,999,939 in federal funding and -$3 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award